Clinical Trial Update: Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pre-clearance of latent tuberculosis infection and revaccination with the BCG vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED